跳至主要内容
临床试验/NCT06109389
NCT06109389进行中(未招募)2 期

The Efficacy of Intravenous Lidocaine Infusion in Chronic Unilateral Migraine Headache Clinical and Laboratory Assessment .Aprospective Randomized Double Blind Controlled Study

Alexandria University1 个研究点 分布在 1 个国家目标入组 80 人开始时间: 2023年10月1日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
2 期
状态
进行中(未招募)
入组人数
80
试验地点
1
主要终点
Verbal analogue scale for pain

研究概览

简要总结

STUDY THE EFFICACY OF INTRAVENOUS LIDOCAINE INFUSION ON PATIENTS WITH CHRONICUNILATERAL MIGRAINE HEADACHE ..NO OF PATIENTS 80..WILLBE DIVIDED INTO 2 GROUPS..FIRST WILL RECEIVE MEDICAL TREATMENT PLUS LIDOCAINE INFUSION ONCE WEEKLY FOR 4 SUCCESIVE WEEKS ,OTHER WILL RECEIVE MEDICAL TREATMENT PLUS SALINE INFUSION SAME REGIMNE,FOLLOW UP USING MONTHLY MIGRAINE DAYS,VAS SCORE,MIDAS SCORE,QUALITY OF LIFE QUESTIONAIRE,PRE AND POST MEASUREMENT OF CALCITONIN GENE RELATED PEPTIDE

详细描述

Group A will receive medical treatment for migraine plus normal saline infusion,Group B will receive medical treatment plus lidocaine infusion at dose from 3 to 4 mg per kg,computer generated random number will be used to identify the selected blocks and give the sequence of patients allocation,guarantee equal random in each group a set of permuted blocks will be generated. Each block has 4 differently ordered treatment assignments.Block 1 (AABB),Block2(ABAB),Block3(BABA),Block 4(ABBA),Block5(BAAB),Block 6(BBAA).

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double (Participant, Care Provider)

入排标准

年龄范围
18 Years 至 55 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • Age (18-55) years for both genders.
  • Patients with chronic unilateral migraine headache for at least (3) month with VASscore more than (4).
  • Patient who failed to respond to conservative treatment as medical treatment algorithm including at least tow preventive trials.
  • Excusion criteria:
  • patient with disabling chronic disease or psychiatric illness
  • unstable cardiac arrhythmia
  • patient refusal red flags

排除标准

  • 未提供

研究组 & 干预措施

infusion of saline

Experimental

infusion saline for 4 successive weeks once weekly over 45 min

干预措施: Lidocaine IV (Drug)

lidocaine infusion

Active Comparator

infusion of lidocaine 3 mg per kg for 2 successive weeks then 4 mg per kg for 2 successive weeks

干预措施: Lidocaine IV (Drug)

结局指标

主要结局

Verbal analogue scale for pain

时间窗: 3 month

verbal analogue scale for pain from( 0) to( 10) as( 0) no pain( 10) severe pain untolerable

Monthly Migraine Days

时间窗: 3 Month

Number of Migraine Attacks Per Month More or less than (15) for chronicity

次要结局

  • Migraine Specific Quality Of Life Questionaire(3 Month)
  • Calcitonin Gene Related Peptide Biomarker.(3 Month)
  • Migraine attack duration(3 Month)
  • Migraine Disability Assessment Questionaire(3 Month)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验